Budhathoki D, Deore B, Finn M, Sanhueza C
RSC Adv. 2022; 12(43):28207-28216.
PMID: 36320230
PMC: 9530798.
DOI: 10.1039/d2ra05158c.
Abdellahi L, Iraji F, Mahmoudabadi A, Hejazi S
Iran Biomed J. 2021; 26(1):1-35.
PMID: 34952558
PMC: 8784899.
DOI: 10.52547/ibj.26.1.35.
Cavalcante T, Medeiros M, Mule S, Palmisano G, Stolf B
Front Cell Infect Microbiol. 2021; 11:671913.
PMID: 34055669
PMC: 8155805.
DOI: 10.3389/fcimb.2021.671913.
Chen W, Cai Y, Fu Q, Chen B, Guo J, Chou J
Angew Chem Int Ed Engl. 2019; 58(29):9866-9870.
PMID: 30990942
PMC: 6660371.
DOI: 10.1002/anie.201903093.
Askarizadeh A, Jaafari M, Khamesipour A, Badiee A
Ther Adv Vaccines. 2017; 5(4-5):85-101.
PMID: 29201374
PMC: 5697592.
DOI: 10.1177/2051013617741578.
Parasite Carbohydrate Vaccines.
Jaurigue J, Seeberger P
Front Cell Infect Microbiol. 2017; 7:248.
PMID: 28660174
PMC: 5467010.
DOI: 10.3389/fcimb.2017.00248.
Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB/c mice.
Kaur S, Kaur T, Joshi J
J Biomed Res. 2016; 30(4):304-13.
PMID: 27533939
PMC: 4946321.
DOI: 10.7555/JBR.30.20150125.
Leishmania lipophosphoglycan: how to establish structure-activity relationships for this highly complex and multifunctional glycoconjugate?.
Forestier C, Gao Q, Boons G
Front Cell Infect Microbiol. 2015; 4:193.
PMID: 25653924
PMC: 4301024.
DOI: 10.3389/fcimb.2014.00193.
A comprehensive analysis of LACK (Leishmania homologue of receptors for activated C kinase) in the context of Visceral Leishmaniasis.
Sinha S, Kumar A, Sundaram S
Bioinformation. 2013; 9(16):832-7.
PMID: 24143055
PMC: 3796886.
DOI: 10.6026/97320630009832.
Leishmania mexicana Gp63 cDNA Using Gene Gun Induced Higher Immunity to L. mexicana Infection Compared to Soluble Leishmania Antigen in BALB/C.
Rezvan H, Rees R, Ali S
Iran J Parasitol. 2012; 6(4):60-75.
PMID: 22347315
PMC: 3279899.
Synthetic neoglycoconjugates of cell-surface phosphoglycans of Leishmania as potential anti-parasite carbohydrate vaccines.
Nikolaev A, Sizova O
Biochemistry (Mosc). 2011; 76(7):761-73.
PMID: 21999537
PMC: 5496670.
DOI: 10.1134/S0006297911070066.
KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis.
Goto Y, Bhatia A, Raman V, Liang H, Mohamath R, Picone A
Clin Vaccine Immunol. 2011; 18(7):1118-24.
PMID: 21632891
PMC: 3147330.
DOI: 10.1128/CVI.05024-11.
A gp63 based vaccine candidate against Visceral Leishmaniasis.
Sinha S, Sundaram S, Singh A, Tripathi A
Bioinformation. 2011; 5(8):320-5.
PMID: 21383918
PMC: 3046035.
DOI: 10.6026/97320630005320.
Carbohydrate vaccines: developing sweet solutions to sticky situations?.
Astronomo R, Burton D
Nat Rev Drug Discov. 2010; 9(4):308-24.
PMID: 20357803
PMC: 3878310.
DOI: 10.1038/nrd3012.
Cefotaxime pharmacokinetics after oral application in the form of 3alpha,7alpha-dihydroxy-12-keto-5beta-cholanate microvesicles in rat.
Golocorbin-Kon S, Mikov M, Arafat M, Lepojevic Z, Mikov I, Sahman-Zaimovic M
Eur J Drug Metab Pharmacokinet. 2009; 34(1):31-6.
PMID: 19462926
DOI: 10.1007/BF03191381.
gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani.
Bhowmick S, Ravindran R, Ali N
Infect Immun. 2008; 76(3):1003-15.
PMID: 18195029
PMC: 2258822.
DOI: 10.1128/IAI.00611-07.
Serodiagnosis of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica in Sanliurfa Province, Turkey, where ACL Is highly endemic.
Yildiz Zeyrek F, Korkmaz M, Ozbel Y
Clin Vaccine Immunol. 2007; 14(11):1409-15.
PMID: 17761525
PMC: 2168175.
DOI: 10.1128/CVI.00133-07.
Characterization of an I-E-restricted, gp63-specific, CD4-T-cell clone from Leishmania major-resistant C3H mice that secretes type 2 cytokines and exacerbates infection with L. major.
Theodos C, Morris R, Bishop J, Jones J, McMaster W, Titus R
Infect Immun. 2004; 72(8):4486-93.
PMID: 15271907
PMC: 470630.
DOI: 10.1128/IAI.72.8.4486-4493.2004.
Present status of antileishmanial vaccines.
Ghosh M, Bandyopadhyay S
Mol Cell Biochem. 2003; 253(1-2):199-205.
PMID: 14619970
DOI: 10.1023/a:1026047429604.
Immune complex antigens as a tool in serodiagnosis of kala-azar.
Chakraborti T, Sarkar D, Ghosh D
Mol Cell Biochem. 2003; 253(1-2):191-8.
PMID: 14619969
DOI: 10.1023/a:1026095328695.